A new drug believed to cause a 20 per cent reduction in heart failure deaths could present a ‘major advance’ in treatment. The drug, LCZ696, helps improve blood flow in heart failure patients. Heart failure is a syndrome caused by the heart not working properly, which can make people vulnerable to serious complications. A new study compared LCZ696 with an existing heart failure drug called enalapril, which is also used to treat high blood pressure.
A new drug believed to cause a 20 per cent reduction in heart failure deaths could present a ‘major advance’ in treatment. The drug, LCZ696, helps improve blood flow in heart failure patients. Heart failure is a syndrome caused by the heart not working properly, which can make people vulnerable to serious complications. A new study compared LCZ696 with an existing heart failure drug called enalapril, which is also used to treat high blood pressure.
Researchers found that LCZ696 is better than enalapril for preventing death from cardiovascular causes and for preventing hospitalisation for heart failure. The results were so striking that they decided to halt the trial.
The Independent, 1st September 2014
Discover More
Parkinson’s disease ‘could be detected early on by brain changes’
Changes in the brain that can be spotted years before physical symptoms of Parkinson’s disease occur might act as an early warning sign for the.
Find Out More
‘Save your money’: no evidence brain health supplements work, say experts
Worldwide panel says it cannot recommend healthy people take ‘memory supplements’. Worldwide panel says it cannot recommend healthy people take.
Find Out More
Eating and dementia
Sitting down for a delicious meal, taking a sip of a nice cup of tea, or working your way through a crisp pint on a summers day are some of the most.
Find Out More